Barclays’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-133,703
| Closed | -$4.61M | – | 3806 |
|
|
2020
Q3 | $4.61M | Buy |
133,703
+55,721
| +71% | +$1.92M | ﹤0.01% | 1013 |
|
|
2020
Q2 | $1.3M | Sell |
77,982
-9,681
| -11% | -$162K | ﹤0.01% | 1765 |
|
|
2020
Q1 | $1.27M | Buy |
87,663
+5,539
| +7% | +$79.9K | ﹤0.01% | 1583 |
|
|
2019
Q4 | $2.75M | Buy |
82,124
+24,198
| +42% | +$810K | ﹤0.01% | 1668 |
|
|
2019
Q3 | $1.21M | Buy |
57,926
+19,026
| +49% | +$398K | ﹤0.01% | 2135 |
|
|
2019
Q2 | $810K | Buy |
38,900
+24,153
| +164% | +$503K | ﹤0.01% | 2469 |
|
|
2019
Q1 | $330K | Buy |
14,747
+12,372
| +521% | +$277K | ﹤0.01% | 2807 |
|
|
2018
Q4 | $57K | Sell |
2,375
-62,153
| -96% | -$1.49M | ﹤0.01% | 3140 |
|
|
2018
Q3 | $1.76M | Buy |
64,528
+58,982
| +1,064% | +$1.61M | ﹤0.01% | 1880 |
|
|
2018
Q2 | $150K | Sell |
5,546
-18,779
| -77% | -$508K | ﹤0.01% | 2899 |
|
|
2018
Q1 | $775K | Sell |
24,325
-131,803
| -84% | -$4.2M | ﹤0.01% | 1999 |
|
|
2017
Q4 | $5.91M | Buy |
156,128
+100,665
| +181% | +$3.81M | ﹤0.01% | 813 |
|
|
2017
Q3 | $1.37M | Buy |
55,463
+55,359
| +53,230% | +$1.37M | ﹤0.01% | 1417 |
|
|
2017
Q2 | $3K | Sell |
104
-4,993
| -98% | -$144K | ﹤0.01% | 3655 |
|
|
2017
Q1 | $111K | Buy |
5,097
+835
| +20% | +$18.2K | ﹤0.01% | 2790 |
|
|
2016
Q4 | $86K | Buy |
4,262
+3,839
| +908% | +$77.5K | ﹤0.01% | 2666 |
|
|
2016
Q3 | $6K | Buy |
+423
| New | +$6K | ﹤0.01% | 3385 |
|